A detailed history of Arizona State Retirement System transactions in Axogen, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 12,801 shares of AXGN stock, worth $302,743. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,801
Previous 11,637 10.0%
Holding current value
$302,743
Previous $126,000 80.95%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

BUY
$10.77 - $17.84 $12,536 - $20,765
1,164 Added 10.0%
12,801 $228,000
Q2 2025

Aug 13, 2025

SELL
$9.29 - $17.81 $3,288 - $6,304
-354 Reduced 2.95%
11,637 $126,000
Q1 2025

May 01, 2025

BUY
$14.56 - $20.11 $174,588 - $241,139
11,991 New
11,991 $221,000
Q3 2023

Nov 06, 2023

BUY
$4.68 - $9.26 $1,123 - $2,222
240 Added 2.11%
11,608 $58,000
Q2 2023

Aug 01, 2023

SELL
$8.5 - $10.38 $2,312 - $2,823
-272 Reduced 2.34%
11,368 $103,000
Q1 2023

Apr 27, 2023

BUY
$7.53 - $10.95 $2,304 - $3,350
306 Added 2.7%
11,640 $109,000
Q4 2022

Feb 07, 2023

BUY
$9.44 - $13.09 $106,992 - $148,362
11,334 New
11,334 $113,000
Q2 2022

Jul 28, 2022

SELL
$6.99 - $10.0 $74,604 - $106,730
-10,673 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$7.26 - $10.7 $638 - $941
88 Added 0.83%
10,673 $85,000
Q4 2021

Feb 04, 2022

SELL
$8.8 - $16.0 $228 - $416
-26 Reduced 0.25%
10,585 $99,000
Q3 2021

Nov 12, 2021

BUY
$15.23 - $21.72 $1,858 - $2,649
122 Added 1.16%
10,611 $168,000
Q2 2021

Aug 02, 2021

SELL
$17.8 - $23.5 $427 - $564
-24 Reduced 0.23%
10,489 $227,000
Q1 2021

May 06, 2021

BUY
$17.18 - $22.6 $876 - $1,152
51 Added 0.49%
10,513 $213,000
Q4 2020

Jan 28, 2021

SELL
$11.5 - $17.96 $3,864 - $6,034
-336 Reduced 3.11%
10,462 $187,000
Q3 2020

Nov 05, 2020

BUY
$10.62 - $13.12 $114,674 - $141,669
10,798 New
10,798 $126,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $1B
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.